Global Cell Saver Market Growth 2023-2029

Global Cell Saver Market Growth 2023-2029

To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.

LPI (LP Information)' newest research report, the “Cell Saver Industry Forecast” looks at past sales and reviews total world Cell Saver sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Saver sales for 2023 through 2029. With Cell Saver sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Saver industry.

This Insight Report provides a comprehensive analysis of the global Cell Saver landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Saver portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cell Saver market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Saver and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Saver.

The global Cell Saver market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cell Saver is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cell Saver is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cell Saver is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cell Saver players cover Haemonetics, Medtronic, LivaNova, BD, Fresenius Kabi and Beijing ZKSK Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Saver market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems

Segmentation by application
Cardiac Surgeries
Orthopedic Surgeries
Organ Transplantation
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Haemonetics
Medtronic
LivaNova
BD
Fresenius Kabi
Beijing ZKSK Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cell Saver market?

What factors are driving Cell Saver market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cell Saver market opportunities vary by end market size?

How does Cell Saver break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.